Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-020709

Director sold 8,687 shares at an average $10.10 ($87,777)

From the SEC's structured data for this filing

Trades in this filing

Canaan IX L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-05-19 Sale : show line 1 in the form −2,500 $10.14 $25,350 4,582,255 I
2016-05-20 Sale : show line 2 in the form −6,187 $10.09 $62,427 4,576,068 I
Open-market sales · 8,687 sh · avg $10.10 · $87,777
Loading xslF345X03/doc4.xml…